Prabhudas Lilladher has initiated a BUY call on Ajanta Pharma, urging investors to seize this opportunity based on the company’s robust branded generics (BGx) franchise, promising financial perform

Market analyst Mitesh Thakkar has suggested four BUY Calls and no SELL Calls for today’s trading session, indicating a bullish outlook for Indian markets.

Indian markets remained weak last week with stock specific action. While the Indian currency faced pressure, stock specific action was witnessed.